医药导报2018，Vol.37Issue(3)：319-322,4.DOI:10.3870/j.issn.1004-0781.2018.03.011
哮喘-慢性阻塞性肺疾病重叠综合征患者的全程化药学服务
Integrated Pharmaceutical Care for Asthma-COPD Overlap Syndrome Patients
摘要
Abstract
Objective To apply intervention of integrated pharmaceutical care (IPC) for asthma-COPD overlap syn-drome patients,so as to reduce the side effects of drugs,enhance medication compliance,promote reasonable drug application,cut down the medical expenses in ACOS patients. Methods A total of 60 ACOS patients were randomly divided into IPC group (group A) (n=34) and contrast group(group B) (n=26).The patients in group A were given IPC measurements such as noso-comial guidance,classroom teaching,regular follow-up,life coaching and psychological advice.While the patients in group B were not given any intervention measures. Results In group A,patients' awareness rate of action and side-effects of drugs were ob-viously increased;Knowledges of inhalation preparation were greatly improved;the ratio of ADRs was significantly reduced;The FEV1 and the value added of FEV1 was dramatically improved.Furthermore,the differences showed statistical significance as com-pared with group B(P<0.05).Total medical costs and anti-bacterial drug costs per year were significantly lower in group A than group B. Conclusion IPC is beneficial to enhance drug compliance,promote reasonable drug application and bring down the medical expenses in ACOS patients.关键词
临床药师/药学服务,全程化/综合征,重叠,哮喘-慢性阻塞性肺疾病/用药教育/用药依从性Key words
Clinical pharmacist/Pharmaceutical care,integrated/Syndrome,overlap,asthma-COPD/Medication educa-tion/Medication compliance分类
医药卫生引用本文复制引用
宋征,郑翠翠,邢树礼,孙绍伟,李保院..哮喘-慢性阻塞性肺疾病重叠综合征患者的全程化药学服务[J].医药导报,2018,37(3):319-322,4.基金项目
滨州医学院科技计划项目(BY2014KJ42) （BY2014KJ42）
